Chemoinformaics analysis of Arabinofuranosyl-L-Arabinose
| Molecular Weight | 282.245 | nRot | 6 |
| Heavy Atom Molecular Weight | 264.101 | nRig | 6 |
| Exact Molecular Weight | 282.095 | nRing | 1 |
| Solubility: LogS | 0.24 | nHRing | 1 |
| Solubility: LogP | -2.912 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 37 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 0 |
| nHetero | 9 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 9 | No. of Arom Bond | 0 |
| nHA | 9 | APOL | 35.9203 |
| nHD | 7 | BPOL | 20.6617 |
| QED | 0.252 |
| Synth | 4.257 |
| Natural Product Likeliness | 1.859 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.008 |
| Pgp-sub | 0.6 |
| HIA | 0.839 |
| CACO-2 | -5.59 |
| MDCK | 0.000718347 |
| BBB | 0.468 |
| PPB | 0.126284 |
| VDSS | 0.428 |
| FU | 0.692202 |
| CYP1A2-inh | 0.005 |
| CYP1A2-sub | 0.018 |
| CYP2c19-inh | 0.005 |
| CYP2c19-sub | 0.051 |
| CYP2c9-inh | 0 |
| CYP2c9-sub | 0.083 |
| CYP2d6-inh | 0 |
| CYP2d6-sub | 0.09 |
| CYP3a4-inh | 0.002 |
| CYP3a4-sub | 0.002 |
| CL | 1.3 |
| T12 | 0.801 |
| hERG | 0.119 |
| Ames | 0.067 |
| ROA | 0.071 |
| SkinSen | 0.022 |
| Carcinogencity | 0.004 |
| EI | 0.01 |
| Respiratory | 0.013 |
| NR-Aromatase | 0.004 |
| Antiviral | No |
| Prediction | 0.744729 |